$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Tumor Volume Change after Chemotheraphy as a Predictive Factor of Disease Free Survival for Osteosarcoma 원문보기

Yonsei medical journal, v.46 no.1, 2005년, pp.119 - 124  

Moon, Seong-Hwan (Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea.) ,  Shin, Kyoo-Ho (Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea.) ,  Suh, Jin-Suck (Department of Diagnostic Radiology, Yonsei University College of Medicine, Seoul, Korea.) ,  Yang, Woo-Ick (Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.) ,  Noh, Jae-Keong (Cancer Center, Yonsei University College of Medicine, Seoul, Korea.) ,  Hahn, Soo-Bong (Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea.)

Abstract AI-Helper 아이콘AI-Helper

Change in tumor volume after chemotherapy appears to have a prognostic significance for the outcome of osteosarcoma. A newly developed volume measurement method based on three-dimensional summation with a proved reproducibility was utilized to measure osteosarcoma tumor volume. This retrospective an...

주제어

참고문헌 (21)

  1. 1 Glasser DB Lane JM Huvos AG Marcove RC Rosen G Survival, prognosis, and therapeutic response in osteogenic sarcoma Cancer 1992 69 698 708 1730120 

  2. 2 Bacci G Ferrari S Delepine N Bertoni F Picci P Mercuri M Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: Study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin J Clin Oncol 1998 16 658 663 9469355 

  3. 3 Goorin AM Abelson HT Frei E III Osteosarcoma: Fifteen years later N Engl J Med 1985 313 1637 1641 3906399 

  4. 4 Rosen G Caparros B Huvos AG Kosloff C Nirenberg A Cacavio A Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy Cancer 1982 49 1221 1230 6174200 

  5. 5 Rosen G Murphy ML Huvos AG Gutierrez M Marcove RC Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma Cancer 1976 37 1 11 1082364 

  6. 6 Bieling P Rehan N Winkler P Helmke K Maas R Fuchs N Tumor size and prognosis in aggressively treated osteosarcoma J Clin Oncol 1996 14 848 858 8622033 

  7. 7 Bronstrom LA Strander H Nilsonne U Survival on osteosarcoma in relation to tumor size and location Clin Orthop 1982 167 250 254 6954021 

  8. 8 Hudson M Jaffe R Jaffe N Ayala A Raymond AK Carrasco H Pediatric osteosarcoma: Therapeutic strategies, results, and prognostic factors derived from a 10-year experience J Clin Oncol 1990 8 1988 1997 2230890 

  9. 9 Meyers PA Heller G Healey J Huvos A Lane J Marcove R Chemotherapy for nonmetastatic osteosarcoma. The Memorial Sloan-Kettering experience J Clin Oncol 1992 10 5 15 1370176 

  10. 10 Pochanugool L Subhadharaphandou T Dhanachai M Hathirat P Sangthawan D Pirabul R Prognostic factor among 130 patients with osteosarcoma Clin Orthop 1997 345 206 214 9418642 

  11. 11 Scranton P DeCicco F Totten T Yunis EJ Prognostic factors in osteosarcoma: A review of 20 years experience at the University of Pittsburgh Health Center hospital Cancer 1975 36 2179 2191 1060506 

  12. 12 Taylor WF Ivins JC Dahlin DC Edmonson JH Pritchard DJ Trends and variability in survival from osteosarcoma Mayo Clin Proc 1978 53 695 700 280739 

  13. 13 Holscher HC Bloem JL Van der Woude HJ Hermans J Nooy MA Taminiau AH Can MRI predict the histopathologic response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 1995 50 384 390 7789022 

  14. 14 Shin KH Moon SH Suh JS Yang WI Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma Clin Orthop 2000 376 200 208 10906876 

  15. 15 Enneking WF Spanier SS Goodman M Current concepts review: Surgical staging of musculoskeletal sarcoma J Bone Joint Surg Am 1980 62 1027 1030 7000786 

  16. 16 Du Bois D Du Bois EF A formula to estimate the approximate surface area if height and weight be known. 1916 (classical article) Nutrition 1989 5 303 311 2520314 

  17. 17 Huvos AG Rosen G Marcove RC Primary osteogenic sarcoma: Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement Arch Pathol Lab Med 1977 101 14 18 299812 

  18. 18 Erlemann R Sciuk J Bosse A Ritter J Kusnierz-Glaz CR Peters PE Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: Assessment with dynamic and static MR imaging and skeletal scintigraphy Radiology 1990 175 791 796 2188300 

  19. 19 Holscher HC Bloem JL Nooy MA Taminiau AH Eulderink F Hermans J The value of MR imaging in monitoring the effect of chemotherapy on bone sarcoma Am J Roentgenol 1990 154 763 769 2107673 

  20. 20 Welling RM Davies AM Pynsent PB Carter SR Grimer RJ The value of computed tomographic measurements in osteosarcoma as a predictor of response to adjuvant chemotherapy Clin Radiol 1994 49 19 23 8299327 

  21. 21 Hanna J Parham DM Fairclough DL Meyer WH Le AH Fletcher BD Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping Invest Radiol 1992 27 367 373 1582820 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로